Premium
Premium statistics

Industry-specific and extensively researched technical data (partially from exclusive partnerships).

A paid subscription is required for full access.

Biosimilar drug and referent sales in France 2011-2013

Value of biosimilar drug sales and their referents in pharmacies in France from 2011 to 2013 (in million euros)

by Statista Research Department, last edited Oct 13, 2014
Biosimilar drug and referent sales in France 2011-2013 This statistic shows the value of biosimilar drugs and reference biological drugs sold in pharmacies in France from 2011 to 2013, in million euros. That year, biosimilar drug sales amounted to almost 80 million euros.
Show more

Value of biosimilar drug sales and their referents in pharmacies in France from 2011 to 2013 (in million euros)

Statista Accounts: Access All Statistics. Starting from $588 / Year
Basic Account
Get to know the platform

You only have access to basic statistics.
This statistic is not included in your account!

Premium Account
Your perfect start with Statista
  • Instant access to 1m statistics
  • Download in XLS, PDF & PNG format
  • Detailed references

$49 / Month *

Corporate Account
Full access

Corporate solution including all features.

* All products require an annual contract.
   Prices do not include sales tax.
Leading companies trust Statista:
paypalgoogleadobepgsamsungtelekom
I think of Statista as Google for researchers. Statista provides you with the information you search for right away.
Dr. Horst Stipp

Dr. Horst Stipp
EVP, Research & Innovation, Advertising Research Foundation

Statistics on "Pharmaceutical trends in Europe"
  • Overview
The most important statistics
  • European Pharmaceutical companies
  • Self-medication market
  • Employment
  • Clinical Trials
Discover Statista
Need help with using Statista for your research? Tutorials and first steps
Further Content: Statistics, Studies, and Topic Pages
Learn more about how Statista can support your business.
Do you have any questions about our business solutions?

We provide you with detailed information about our Corporate Account.